- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | IKONISYS: Aliko Scientific: Hospitex International Signs First Agreement With the Uzbek Oncology Institute for the Feasibility Study of a National Urine24 Screening Project | - | Euronext | ||
| Do | Aliko Scientific SA: Aliko Scientific: Hospitex International Signs First Agreement With the Uzbek Oncology Institute for the Feasibility Study of a National Urine24 Screening Project | 246 | Business Wire | Confirmation of the growing international interest in Urine24 and significant recognition of Aliko Scientific's expertise in large-scale oncological diagnostic solutions Immediate launch... ► Artikel lesen | |
| ONCOLOGY INSTITUTE Aktie jetzt für 0€ handeln | |||||
| 09.07. | BTIG hebt Kursziel für Oncology Institute Aktie nach Umschuldung auf 9 US-Dollar an | 3 | Investing.com Deutsch | ||
| 09.07. | BTIG raises Oncology Institute stock price target to $9 on debt refinancing | 2 | Investing.com | ||
| 07.07. | Oncology Institute, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.07. | TOI Management, LLC: The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity | 1 | GlobeNewswire (USA) | ||
| 07.07. | Why Oncology Institute's (TOI) Analyst Upgrades Put Its Community Cancer Care Growth Story in Focus | 2 | Insider Monkey | ||
| 06.07. | Lake Street initiates Oncology Institute stock coverage with buy rating | 1 | Investing.com | ||
| 18.06. | Oncology Institute, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 17.06. | Needham raises Oncology Institute stock price target to $7 on growth outlook | 1 | Investing.com | ||
| 09.06. | How Much Upside is Left in The Oncology Institute (TOI)? Wall Street Analysts Think 38.07% | 4 | Zacks | ||
| 08.06. | Oncology Institute To Rally Over 64%? Here Are 10 Top Analyst Forecasts For Monday | 1 | Benzinga.com | ||
| 22.05. | Oncology Institute, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.05. | The Oncology Institute GAAP EPS of -$0.02 beats by $0.07, revenue of $147.4M beats by $5.42M | 1 | Seeking Alpha | ||
| 07.05. | Oncology Institute, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.04. | Here's What Powered The Oncology Institute's (TOI) Gains | 1 | Insider Monkey | ||
| 13.04. | Oncology Institute reports $1.8M Medicare savings in latest period | 1 | Investing.com | ||
| 13.04. | TOI Management, LLC: The Oncology Institute Achieves $1.8 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 3, Marking Significant Period-Over-Period Improvement | 4 | GlobeNewswire (USA) | ||
| 06.04. | TOI Management, LLC: The Oncology Institute Names Minh Merchant Chief Legal Officer | 1 | GlobeNewswire (USA) | ||
| 13.03. | Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket | 1 | Benzinga.com |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 71,98 | 0,00 % | BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: Should You Buy? | ||
| FRESENIUS | 44,250 | +1,03 % | Fresenius hinter Siemens Energy und RWE auf Platz 3 im DAX - startet die Aktie jetzt wieder ... | Die Aktie von Fresenius gehört heute zu den stärksten Titeln des Tages im deutschen Leitindex DAX. Hinter Siemens Energy und RWE rangiert Fresenius auf Rang drei mit einem Plus von 2,1 Prozent auf 42... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 35,560 | +1,43 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 43,880 | +1,41 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,650 | -6,75 % | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| ADAPTHEALTH | 10,960 | +1,86 % | Cardinal Health To Buy AdaptHealth's Diabetes Unit, Strive Medical For $360 Mln Total | WASHINGTON (dpa-AFX) - Healthcare services company Cardinal Health, Inc. (CAH) announced late Monday its agreement to acquire the Diabetes Health business of AdaptHealth Corp. (AHCO), as well... ► Artikel lesen | |
| GERRESHEIMER | 27,960 | +6,39 % | Gerresheimer-Aktie: Sind 40 € wieder machbar? | Die Gerresheimer-Aktie hat sich deutlich von ihrem Tief im April bei rund 17 € erholt. Am Freitag notiert sie bei 26 € und damit wieder auf dem Niveau zu Jahresbeginn. Nach der Aufarbeitung der Bilanzprobleme... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 28,020 | +0,79 % | Carl Zeiss Meditec: Was Insider vor JPMorgan sehen | ||
| BILLIONTOONE | 127,77 | -0,91 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| GENEDX | 60,58 | -4,42 % | NSE - GeneDx Holdings Corp. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| HEARTFLOW | 25,360 | +5,14 % | Heartflow, Inc.: Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026 | ||
| AVEANNA HEALTHCARE | 9,665 | +6,44 % | Aveanna Healthcare (AVAH) Just Flashed Golden Cross Signal: Do You Buy? | ||
| PROGYNY | 31,620 | +3,00 % | Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report | ||
| PROCEPT BIOROBOTICS | 17,700 | +0,85 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,680 | -1,16 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen |
ONCOLOGY INSTITUTE INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 5,190 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ONCOLOGY INSTITUTE INC finden Sie auf Wallstreet Online.